TRT Hematocrit: When to Worry & How to Lower It (2026)

You get your labs back on TRT and your doctor circles the hematocrit number in red. Maybe it's 51%. Maybe it's 54%. Either way, the conversation that follows usually lacks nuance: "Your blood is too thick. We need to lower your dose or stop testosterone."

That reaction is understandable but often premature. Elevated hematocrit on TRT is the most common side effect of testosterone replacement, affecting roughly 20% of men on therapy. It's also one of the most manageable, once you understand what's actually happening and what the evidence says about when to worry.

Here's what's actually going on, when the numbers matter, what to do at each level, and how to track the trend so you're making decisions based on data rather than a single scary lab result.

What Hematocrit Is and Why TRT Raises It

Hematocrit is the percentage of your blood volume made up of red blood cells. A normal range for adult men is roughly 38-50%. When you inject testosterone, your body responds by producing more erythropoietin (EPO), which signals your bone marrow to make more red blood cells. More red blood cells means higher hematocrit.

This is called testosterone-induced erythrocytosis. It's a known, dose-dependent effect, not an allergic reaction or a sign that something is wrong with your body. In fact, it's partly how testosterone improves energy and exercise capacity: more red blood cells means more oxygen delivery to your tissues.

The problem starts when hematocrit gets too high. Thicker blood flows less easily, which increases the workload on your heart and raises the risk of blood clots, stroke, and cardiovascular events. The question is: how high is too high?

The Real Risk Thresholds

Here's where the conversation gets more nuanced than most TRT forums allow. The 54% threshold cited in most guidelines (AUA, Endocrine Society) comes from hematology research on polycythemia vera, a blood cancer where hematocrit can exceed 60%. That's a very different condition from TRT-induced erythrocytosis.

Recent research suggests the cardiovascular risk from TRT-induced erythrocytosis may be lower than the risk from polycythemia vera at the same hematocrit level. The two conditions produce different types of red blood cells and different clotting profiles. That said, the current clinical consensus still uses 54% as the intervention threshold, and that's a reasonable approach until better TRT-specific data emerges.

What matters more than any single number is the trend. If your hematocrit has been climbing steadily from 47% to 49% to 52% over three lab draws, that trajectory tells you something important, even if 52% is technically within some labs' reference range.

The Intervention Ladder: What to Do at Each Level

Think of hematocrit management as a ladder. Start at the bottom with the least invasive interventions and only escalate if the simpler steps don't work.

Level 1: Below 50% — Monitor

You're in the normal range. No action needed beyond routine monitoring at your regular lab intervals (every 3-6 months once stable). Stay hydrated.

Level 2: 50-52% — Investigate and Optimize

• Hydration audit: Are you drinking enough water? Dehydration concentrates blood and inflates hematocrit readings. Drink 80-100 oz daily, more if you train hard or live somewhere hot.
• Sleep apnea screening: Untreated sleep apnea is one of the most overlooked contributors to elevated hematocrit. Chronic low oxygen at night triggers EPO production independently of testosterone. Get a sleep study if you snore, wake up tired, or your partner says you stop breathing.
• Injection frequency: More frequent, smaller injections (daily or every-other-day) produce lower peak testosterone levels, which reduces EPO stimulation. Switching from weekly to daily injections has helped many men bring hematocrit down without lowering their total dose.

Level 3: 52-54% — Active Management

Everything from Level 2, plus:

• Dose reduction: Consider lowering your total weekly dose by 10-20%. You may still feel great on a slightly lower dose while keeping hematocrit in a safer range.
• Naringin or grapefruit: Some community members report modest hematocrit reductions with naringin supplementation. The evidence is anecdotal, but the risk is low. Note that grapefruit interacts with some medications.
• Blood donation: Donating a pint of whole blood (about 500mL) reduces hematocrit by roughly 3 percentage points. You can donate every 56 days. This is a straightforward and socially useful intervention.

Level 4: Above 54% — Medical Intervention

• Therapeutic phlebotomy: Same as blood donation but prescribed by your doctor. Can be done more frequently than standard donation. Your doctor orders the volume and frequency based on your levels.
• Dose reduction or temporary cessation: If phlebotomy isn't bringing levels down, reducing or pausing TRT may be necessary. This should be a conversation with your prescriber, not a unilateral decision.
• Hematology referral: If hematocrit stays elevated despite dose reduction, rule out primary polycythemia or other hematological conditions. TRT may have unmasked a pre-existing issue.

Hidden Contributors Most Doctors Miss

Before blaming testosterone and reaching for a dose reduction, investigate these common confounders:

How to Monitor and Track the Trend

Hematocrit management is about the trend line, not any single data point. Here's a practical monitoring protocol:

Track each lab result alongside your TRT dose, injection frequency, and any interventions (phlebotomy, hydration changes, CPAP start). When you see the trend, the right decision becomes obvious.

Track your TRT labs alongside your protocol

• Log dose changes and see them on your health metric timeline
• Correlate hematocrit trends with protocol adjustments
• Track 1 compound free forever

Get Regimen Free

Putting It Together

Elevated hematocrit on TRT is common, expected, and in most cases manageable without stopping therapy. The conversation has shifted in recent years from "panic at 50%" to a more nuanced understanding of risk thresholds, confounding factors, and the difference between TRT-induced erythrocytosis and primary blood disorders.

The practical takeaway: hydrate properly, get screened for sleep apnea, consider more frequent injections if your hematocrit is trending up, and use phlebotomy when lifestyle adjustments aren't enough. Track the trend, not any single number.

And if your doctor's only response to a high hematocrit is to discontinue TRT, bring this ladder approach to the conversation. Most experienced TRT prescribers will work through the steps with you before pulling the plug on therapy that's otherwise working well.

Common Questions